MARKET

PCRX

PCRX

Pacira Biosciences Inc
NASDAQ
22.60
-0.67
-2.88%
After Hours: 22.60 0 0.00% 16:41 03/31 EDT
OPEN
23.61
PREV CLOSE
23.27
HIGH
23.61
LOW
22.32
VOLUME
657.77K
TURNOVER
--
52 WEEK HIGH
27.64
52 WEEK LOW
18.80
MARKET CAP
915.07M
P/E (TTM)
144.69
1D
5D
1M
3M
1Y
5Y
1D
Pacira says EXPAREL lowers total cost of care in real-world orthopedic studies
Reuters · 1d ago
Weekly Report: what happened at PCRX last week (0323-0327)?
Weekly Report · 1d ago
Pacira BioSciences Is Maintained at Equal-Weight by Barclays
Dow Jones · 5d ago
Pacira BioSciences Price Target Cut to $25.00/Share From $27.00 by Barclays
Dow Jones · 5d ago
Barclays Maintains Equal-Weight on Pacira BioSciences, Lowers Price Target to $25
Benzinga · 5d ago
Pacira price target lowered to $25 from $27 at Barclays
TipRanks · 5d ago
PACIRA BIOSCIENCES <PCRX.O>: BARCLAYS CUTS TARGET PRICE TO $25 FROM $27
Reuters · 5d ago
Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX), Pacira Pharmaceuticals (PCRX) and Alnylam Pharma (ALNY)
TipRanks · 5d ago
More
About PCRX
Pacira BioSciences, Inc. is the holding company for its subsidiary, Pacira Pharmaceuticals, Inc. The Company has three commercial-stage non-opioid treatments: EXPAREL (bupivacaine liposome injectable suspension), a long-acting local analgesic approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain, and iovera, a handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The Company is also advancing the development of PCRX-201, a locally administered gene therapy with the potential to treat largely prevalent diseases like osteoarthritis.

Webull offers Pacira Biosciences Inc stock information, including NASDAQ: PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PCRX stock methods without spending real money on the virtual paper trading platform.